A randomized clinical trial comparing effectiveness of 4RIF and 9INH for treatment of latent TB infection

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/632857

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Treatment of latent tuberculosis infection (LTBI) is one intervention that is known to prevent the occurrence of active TB. Current treatment is based on a six to nine month course of isoniazid. The treatment has side effects in some people and many people do not complete the treatment. The present study is to test an alternative treatment regimen (4 months of rifampicin) which has fewer side-effects and is more likely to be completed.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2015

Funding Scheme: Project Grants

Funding Amount: $496,875.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Public Health and Health Services not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Disease control | Prevention | Tuberculosis | disease control | global health | health programs | prevention

Related Links